Amr Abdel Razek, Chairperson of STIO Life Science (SLS), announced that the company has invested EGP 400m in the Egyptian market during 2023/2024. These funds have been directed toward development initiatives and securing the necessary business licenses. Abdel Razek highlighted the company’s recent achievement in establishing a kidney filter manufacturing facility, which will help save […]

The post STIO Life Science invests EGP 400m to localize Egypt’s pharmaceutical industry appeared first on Dailynewsegypt.